What is a biosimilar?

A biosimilar is a biological product that is highly similar to and has no clinically meaningful differences from an existing FDA-approved reference product. When patients are prescribed a biological product, biosimilar and interchangeable products can offer additional treatment options, potentially lowering health care costs.

We need policymakers to take action to increase access to biosimilars for patients living with chronic conditions. Sign up to tell legislators to cut health care costs by making biosimilars more accessible!